Metropolis Healthcare Limited, commonly referred to as Metropolis, is a leading diagnostic service provider headquartered in India. Established in 1980, the company has grown to become a prominent player in the healthcare industry, with a strong presence across major operational regions including Mumbai, Delhi, and Bengaluru. Specialising in pathology and diagnostic services, Metropolis offers a comprehensive range of tests, including advanced molecular diagnostics and preventive health check-ups. Their commitment to quality and innovation sets them apart, as they utilise state-of-the-art technology and adhere to stringent quality standards. With over four decades of experience, Metropolis has achieved significant milestones, including numerous accreditations and a vast network of laboratories and collection centres. This positions them as a trusted name in the healthcare sector, dedicated to enhancing patient care through accurate and timely diagnostics.
How does Metropolis Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Metropolis Healthcare's score of 21 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Metropolis Healthcare reported total carbon emissions of approximately 7,187,030 kg CO2e. This figure includes 317,680 kg CO2e from Scope 1 emissions, 6,825,350 kg CO2e from Scope 2 emissions, and 44,000 kg CO2e from Scope 3 emissions. The previous year, 2022, the total emissions were approximately 10,254,330 kg CO2e, indicating a reduction in emissions over the year. Despite these figures, Metropolis Healthcare has not disclosed any specific reduction targets or climate pledges. The company has not cascaded any emissions data from a parent organization, and all reported data is directly from Metropolis Healthcare Limited. The emissions intensity per rupee of turnover for Scope 1 and Scope 2 in 2023 was 0.000947, reflecting the company's operational efficiency in relation to its revenue. As of now, Metropolis Healthcare's climate commitments remain unspecified, and there are no documented reduction initiatives or targets.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 220,950 | 000,000 |
| Scope 2 | 9,815,380 | 0,000,000 |
| Scope 3 | 218,000 | 00,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Metropolis Healthcare has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.